Compare On-Q-ity vs SourceMDx
Customers evaluate the quality of On-Q-ity's products using the following success metrics.
Overview
On-Q-ity is 15 yrs old and is based in United States.
On-Q-ity is a life sciences company focused on circulating tumor cell (CTC) capture and characterization. The company is developing products and services for clinical researchers and physicians that will enhance decision-making across multiple cancer types. On-Q-ity's goals is to increase the success of oncology drug development, improve patient treatment outcomes and increase survival rates.
SourceMDx is 26 yrs old and is based in United States.
Source MDx is developing and commercializing prognostic, predictive and early detection molecular diagnostic (Precision Profile ) assays and tests for cancer and other inflammatory diseases. The company's lead development programs, in collaboration with the Dana-Farber Cancer Institute, includes a family of Precision Profile assays for prostate cancer designed to: improve early diagnosis with a goal to reduce the need for biopsies, predict the aggressiveness of the cancer, better define prognosis and more effectively stratify patients for drug response - all of which may serve to improve the management of patient care and lower healthcare costs.
Demo Video
Investors
Mohr Davidow Ventures, Physic Ventures
Pfizer Venture Investments
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because On-Q-ity has not claimed their profile.
Work for On-Q-ity? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for On-Q-ity?
Claim your profile now.
Information not available because SourceMDx has not claimed their profile.
Work for SourceMDx? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for SourceMDx?
Claim your profile now.
News & Analysis
On-Q-ity has been mentioned in our research 1 time.
SourceMDx has not been mentioned in our research.
